Chapter 2-40 — Scheduling and Rescheduling of Controlled Substances
9 rules · Departmental· official chapter page
| 2-40.0001 | Scheduling AND Rescheduling of Controlled Substances | |
| 2-40.001 | Levo-Alpha-Acetyl-Methadol (LAAM) Rescheduled as a Schedule II Controlled Substance | |
| 2-40.002 | Transfer of Flunitrazepan to Schedule I, Section 893.03(1)(a), F.S | |
| 2-40.003 | Addition of Ketamine to Schedule III, Section 893.03(3), F.S | |
| 2-40.004 | Addition of Gamma-hydroxybutyric Acid (GHB to Schedule II, Section 893.03(2)(a), F.S | |
| 2-40.005 | Rescheduling Specified Drug Products Containing Hydrocodone as Schedule III Substances (Repealed) | 1/2/2008 |
| 2-40.006 | Addition of Alphamethyltryptamine (AMT) to Schedule I, Subsection 893.03(1), F.S (Repealed) | 2/2/2012 |
| 2-40.007 | Rescheduling of a Drug Product in Finished Dosage Formulation That Has Been Approved by the U.S. Food and Drug Administration That Contains Cannabidiol (2-[1R-3-methyl-6R-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol) Derived from Cannabis and No More Than 0.1 Percent (w/w) Residual Tetrahydrocannabinols | 2/7/2019 |
| 2-40.008 | Rescheduling of Drug Product Under Section 893.0355 | 11/23/2025 |